{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:53:32Z","timestamp":1785488012312,"version":"3.56.0"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Chondrosarcomas are common primary malignant bone tumors; however, comprehensive bibliometric analysis in this field has not yet been conducted. Therefore, this study aimed to explore the research hotspots and trends in the field of chondrosarcoma through bibliometric analysis to help researchers understand the current status and direction of research in the field.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Articles and reviews related to chondrosarcoma published between 2003 and 2022 were retrieved from the Web of Science. Countries, institutions, authors, journals, references, and keywords in this field were visualized and analyzed using CtieSpace and VOSviewer software.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between 2003 and 2022, 4,149 relevant articles were found. The number of articles published on chondrosarcoma has increased significantly annually, mainly from 569 institutions in China and the United States, and 81 in other countries. In total, 904 authors participated in the publication of studies related to chondrosarcomas. Over the past 20\u00a0years, articles on chondrosarcoma have been published in 958 academic journals, with <jats:italic>Skeletal Radiology<\/jats:italic> having the highest number of publications. Furthermore, keywords such as \u201cgene expression,\u201d \u201cradiotherapy,\u201d \u201cexperience,\u201d and \u201capoptosis\u201d have been popular in recent years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Over the past 20\u00a0years, the global trend in chondrosarcoma research has primarily been clinical research, with basic research as a supplement. In the future, communication and exchange between countries and institutions should be strengthened. Further, the future main research hotspots in the field of chondrosarcoma include mutated genes and signaling pathways, precision surgical treatment, proton therapy, radiation therapy, chemotherapy, immunotherapy, and other aspects.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1431958","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T04:35:03Z","timestamp":1722573303000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Global research development of chondrosarcoma from 2003 to 2022: a bibliometric analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Hansong","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanning","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.2106\/jbjs.16.00803","article-title":"Early results of acetabular reconstruction after wide periacetabular oncologic resection","volume":"99","author":"Abdel","year":"2017","journal-title":"J. Bone Jt. Surg."},{"key":"B2","doi-asserted-by":"publisher","first-page":"100222","DOI":"10.1016\/j.jbo.2019.100222","article-title":"Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathway","volume":"15","author":"Addie","year":"2019","journal-title":"J. Bone Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.jtho.2016.03.010","article-title":"The state of lung cancer research: a global analysis","volume":"11","author":"Aggarwal","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/s0046-8177(96)90341-x","article-title":"Chondrocytic cell differentiation in clear cell chondrosarcoma","volume":"27","author":"Aigner","year":"1996","journal-title":"Hum. Pathol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5340616","DOI":"10.1155\/2019\/5340616","article-title":"The role of 3D printing in medical applications: a state of the art","volume":"2019","author":"Aimar","year":"2019","journal-title":"J. Healthc. Eng."},{"key":"B6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2174\/0929867329666220801152347","article-title":"The fractal viewpoint of tumors and nanoparticles","volume":"30","author":"Alexiou","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/path.2913","article-title":"IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours","volume":"224","author":"Amary","year":"2011","journal-title":"J. Pathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0736-0266(00)00022-X","article-title":"Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosarcoma","volume":"19","author":"Asp","year":"2001","journal-title":"J. Orthop. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.18502\/ken.v3i2.1790","article-title":"Clinical application of new immobilization system in seated position for proton therapy","volume":"3","author":"Balakin","year":"2018","journal-title":"KnE Energy"},{"key":"B10","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00280-012-1968-x","article-title":"Clinical activity of mTOR inhibition in combination with cyclophosphamide in the treatment of recurrent unresectable chondrosarcomas","volume":"70","author":"Bernstein-Molho","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrc2869","article-title":"Cartilage tumours and bone development: molecular pathology and possible therapeutic targets","volume":"10","author":"Bovee","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1302\/0301-620X.96B12.34622","article-title":"Clinical outcome of pedestal cup endoprosthetic reconstruction after resection of a peri-acetabular tumour","author":"Bus","year":"2014","journal-title":"Bone Jt. J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s11999-016-4805-4","article-title":"LUMiC\u00ae endoprosthetic reconstruction after periacetabular tumor resection: short-term results","volume":"475","author":"Bus","year":"2017","journal-title":"Clin. Orthop. Relat. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1158\/1535-7163.MCT-13-0731","article-title":"Hedgehog pathway inhibition in chondrosarcoma using the smoothened inhibitor IPI-926 directly inhibits sarcoma cell growth","volume":"13","author":"Campbell","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"16773","DOI":"10.3390\/ijms242316773","article-title":"Radiation and immune checkpoint inhibitors: combination therapy for treatment of hepatocellular carcinoma","volume":"24","author":"Chami","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2549616","DOI":"10.1155\/2016\/2549616","article-title":"Extracorporeal irradiation and reimplantation with total hip arthroplasty for periacetabular pelvic resections: a review of 9 cases","volume":"2016","author":"Chan","year":"2016","journal-title":"Sarcoma"},{"key":"B17","doi-asserted-by":"publisher","first-page":"300060520917275","DOI":"10.1177\/0300060520917275","article-title":"Three-dimensional printed implant for reconstruction of pelvic bone after removal of giant chondrosarcoma: a case report","volume":"48","author":"Chen","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cmpb.2015.10.020","article-title":"Image-guided installation of 3D-printed patient-specific implant and its application in pelvic tumor resection and reconstruction surgery","volume":"125","author":"Chen","year":"2016","journal-title":"Comput. Methods Programs Biomed."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6682","DOI":"10.4049\/jimmunol.0900080","article-title":"PD-1-mediated suppression of IL-2 production induces CD8+ T cell anergy in vivo","volume":"182","author":"Chikuma","year":"2009","journal-title":"J. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/cncr.32515","article-title":"Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma","volume":"126","author":"Chow","year":"2020","journal-title":"Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.15953.1","article-title":"Chondrosarcoma: biology, genetics, and epigenetics","volume":"7","author":"Chow","year":"2018","journal-title":"F1000Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"17588359231199877","DOI":"10.1177\/17588359231199877","article-title":"Role of immunotherapy in chondrosarcoma: a case report and review of the literature","volume":"15","author":"Cohen-Nowak","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.3390\/ijms19082453","article-title":"Role of mTOR signaling in tumor microenvironment: an overview","volume":"19","author":"Conciatori","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.5301\/hipint.5000306","article-title":"Reconstruction of periacetabular tumours with saddle prosthesis or custom-made prosthesis, functional results and complications","volume":"26","author":"Danisman","year":"2016","journal-title":"Hip Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.3390\/ijms23116241","article-title":"Roles of Notch signaling in the tumor microenvironment","volume":"23","author":"D\u2019Assoro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1158\/2767-9764.CRC-22-0397","article-title":"Distinct IDH1\/2-associated methylation profile and enrichment of TP53 and TERT mutations distinguish dedifferentiated chondrosarcoma from conventional chondrosarcoma","volume":"3","author":"Dermawan","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.3390\/cancers15184581","article-title":"Mesenchymal chondrosarcoma from diagnosis to clinical trials","volume":"15","author":"Dudzisz-Sledz","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12957-015-0723-2","article-title":"Implantation of customized 3-D printed titanium prosthesis in limb salvage surgery: a case series and review of the literature","volume":"13","author":"Fan","year":"2015","journal-title":"World J. Surg. Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s13014-021-01961-9","article-title":"Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity","volume":"16","author":"Gordon","year":"2021","journal-title":"Radiat. Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1025876","DOI":"10.3389\/fonc.2022.1025876","article-title":"Emerging trends and focus of giant cell tumor of bone research from 2001-2021: a visualization research","volume":"12","author":"Han","year":"2022","journal-title":"Front. Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s11060-019-03129-8","article-title":"Proton therapy for skull-base chondrosarcoma, a single-institution outcomes study","volume":"142","author":"Holtzman","year":"2019","journal-title":"J. Neuro-Oncology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s00264-018-3785-2","article-title":"Pelvic reconstructions following peri-acetabular bone tumour resections using a cementless ice-cream cone prosthesis with dual mobility cup","volume":"42","author":"Issa","year":"2018","journal-title":"Int. Orthop."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1093\/annonc\/mdt391","article-title":"GDC-0449 in patients with advanced chondrosarcomas: a French sarcoma group\/US and French national cancer institute single-arm phase II collaborative study","volume":"24","author":"Italiano","year":"","journal-title":"Ann. Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1093\/annonc\/mdt374","article-title":"Advanced chondrosarcomas: role of chemotherapy and survival","volume":"24","author":"Italiano","year":"","journal-title":"Ann. Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejso.2012.10.002","article-title":"Modular hemipelvic endoprosthesis reconstruction--experience in 100 patients with mid-term follow-up results","volume":"39","author":"Ji","year":"2013","journal-title":"Eur. J. Surg. Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00204-014-1433-1","article-title":"The Hedgehog pathway: role in cell differentiation, polarity and proliferation","volume":"89","author":"Jia","year":"2015","journal-title":"Arch. Toxicol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/cncr.21848","article-title":"Differential expression of VEGF-A and angiopoietins in cartilage tumors and regulation by interleukin-1beta","volume":"106","author":"Kalinski","year":"2006","journal-title":"Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1007\/s11999-014-4009-8","article-title":"What are the functional results and complications from allograft reconstruction after partial hemipelvectomy of the pubis?","volume":"473","author":"Karim","year":"2015","journal-title":"Clin. Orthop. Relat. Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/17453674.2020.1732016","article-title":"Modified Harrington\u2019s procedure for periacetabular metastases in 89 cases: a reliable method for cancer patients with good functional outcome, especially with long expected survival","volume":"91","author":"Kask","year":"2020","journal-title":"Acta Orthop."},{"key":"B41","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1159\/000509386","article-title":"Skull base chordomas and chondrosarcomas","volume":"110","author":"Kremenevski","year":"2020","journal-title":"Neuroendocrinology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1302\/0301-620X.99B2.BJJ-2016-0654.R1","article-title":"Reconstruction with 3D-printed pelvic endoprostheses after resection of a pelvic tumour","volume":"99","author":"Liang","year":"2017","journal-title":"Bone Jt. J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.3390\/cancers13184682","article-title":"The multiple faces of MNT and its role as a MYC modulator","volume":"13","author":"Liano-Pons","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1007\/s11999.0000000000000165","article-title":"Upshifting the ipsilateral proximal femur may provide satisfactory reconstruction of periacetabular pelvic bone defects after tumor resection","volume":"476","author":"Lin","year":"2018","journal-title":"Clin. Orthop. Relat. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"120227","DOI":"10.1109\/access.2021.3092192","article-title":"Bibliometric analysis of the blockchain scientific evolution: 2014\u20132020","volume":"9","author":"Luo","year":"2021","journal-title":"IEEE Access"},{"key":"B46","doi-asserted-by":"publisher","first-page":"144","DOI":"10.24976\/Discov.Med.202335175.15","article-title":"Proprotein convertase furin regulates melanogenesis via the Notch signaling pathway","volume":"35","author":"Luo","year":"2023","journal-title":"Discov. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"731933","DOI":"10.3389\/fimmu.2021.731933","article-title":"A bibliometric analysis of pyroptosis from 2001 to 2021","volume":"12","author":"Ma","year":"2021","journal-title":"Front. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/cbdd.14118","article-title":"Long noncoding RNA SNHG7-miRNA-mRNA axes crosstalk with oncogenic signaling pathways in human cancers","volume":"101","author":"Malakoti","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"B49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/hed.25479","article-title":"Proton therapy for skull base tumors: a review of clinical outcomes for chordomas and chondrosarcomas","volume":"41","author":"Mercado","year":"2019","journal-title":"Head. Neck"},{"key":"B51","doi-asserted-by":"publisher","first-page":"840956","DOI":"10.3389\/fimmu.2022.840956","article-title":"A bibliometric and knowledge-map analysis of CAR-T cells from 2009 to 2021","volume":"13","author":"Miao","year":"2022","journal-title":"Front. Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"772263","DOI":"10.3389\/fonc.2021.772263","article-title":"Metabolic pathways and targets in chondrosarcoma","volume":"11","author":"Micaily","year":"2021","journal-title":"Front. Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.addr.2016.11.006","article-title":"Proton therapy - present and future","volume":"109","author":"Mohan","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.critrevonc.2018.09.001","article-title":"Chondrosarcoma: an overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets","volume":"131","author":"Nazeri","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"22275","DOI":"10.1038\/srep22275","article-title":"Visualization of complex DNA double-strand breaks in a tumor treated with carbon ion radiotherapy","volume":"6","author":"Oike","year":"2016","journal-title":"Sci. Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13569-016-0064-0","article-title":"Response to anti-PD1 therapy with nivolumab in metastatic sarcomas","volume":"6","author":"Paoluzzi","year":"2016","journal-title":"Clin. Sarcoma Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11864-022-00951-7","article-title":"Systemic therapy for chondrosarcoma","volume":"23","author":"Rock","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5603\/ocp.2021.0032","article-title":"Expert recommendation on diagnostic-therapeutic management in skin carcinomas","volume":"18","author":"Rutkowski","year":"2022","journal-title":"Oncol. Clin. Pract."},{"key":"B59","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/01.cco.0000129678.72521.e5","article-title":"Genetics of chondrosarcoma and related tumors","volume":"16","author":"Sandberg","year":"2004","journal-title":"Curr. Opin. Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/PAP.0b013e31827b654d","article-title":"Mutations in the isocitrate dehydrogenase genes IDH1 and IDH2 in tumors","volume":"20","author":"Schaap","year":"2013","journal-title":"Adv. Anat. Pathol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1158\/1535-7163.MCT-14-0711","article-title":"MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma","volume":"14","author":"Slotkin","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"B62","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/cam4.4849","article-title":"Mesenchymal chondrosarcoma: an Australian multi-centre cohort study","volume":"12","author":"Strach","year":"2023","journal-title":"Cancer Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13569-020-00138-4","article-title":"Long lasting response with trabectedin monotherapy in relapsed metastatic mesenchymal chondrosarcoma","volume":"10","author":"Tansir","year":"2020","journal-title":"Clin. Sarcoma Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/ng.2668","article-title":"Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma","volume":"45","author":"Tarpey","year":"2013","journal-title":"Nat. Genet."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(17)30624-1","article-title":"Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial","volume":"18","author":"Tawbi","year":"2017","journal-title":"Lancet Oncol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2353\/ajpath.2006.050001","article-title":"Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation","volume":"168","author":"Tiet","year":"2006","journal-title":"Am. J. Pathol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3390\/ijms24021361","article-title":"Biology and management of high-grade chondrosarcoma: an update on targets and treatment options","volume":"24","author":"Tlemsani","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.pathol.2017.05.003","article-title":"PD-1 and PD-L1 expression in bone and soft tissue sarcomas","volume":"49","author":"Torabi","year":"2017","journal-title":"Pathology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"745360","DOI":"10.1155\/2013\/745360","article-title":"Biological reconstruction following the resection of malignant bone tumors of the pelvis","volume":"2013","author":"Traub","year":"2013","journal-title":"Sarcoma"},{"key":"B70","doi-asserted-by":"publisher","first-page":"249757","DOI":"10.1155\/2014\/249757","article-title":"Chemotherapy improved prognosis of mesenchymal chondrosarcoma with rare metastasis to the pancreas","volume":"2014","author":"Tsukamoto","year":"2014","journal-title":"Case Rep. Oncol. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"B72","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1634\/theoncologist.2017-0574","article-title":"Outcome of first-line systemic treatment for unresectable conventional, dedifferentiated, mesenchymal, and clear cell chondrosarcoma","volume":"24","author":"van Maldegem","year":"2019","journal-title":"Oncologist"},{"key":"B73","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1002\/cam4.4019","article-title":"Prognostic importance of IDH mutations in chondrosarcoma: an individual patient data meta-analysis","volume":"10","author":"Vuong","year":"2021","journal-title":"Cancer Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00264-017-3645-5","article-title":"Computer-aided designed, three dimensional-printed hemipelvic prosthesis for peri-acetabular malignant bone tumour","volume":"42","author":"Wang","year":"2018","journal-title":"Int. Orthop."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e0127263","DOI":"10.1371\/journal.pone.0127263","article-title":"Reconstruction with modular hemipelvic endoprosthesis after pelvic tumor resection: a report of 50 consecutive cases","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"B76","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1186\/s12885-019-6049-7","article-title":"Reconstruction with a novel combined hemipelvic endoprosthesis after resection of periacetabular tumors involving the sacroiliac joint: a report of 25 consecutive cases","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Cancer"},{"key":"B77","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1200\/JCO.2017.75.1743","article-title":"Osteosarcoma, chondrosarcoma, and chordoma","volume":"36","author":"Whelan","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1053\/j.seminoncol.2017.10.004","article-title":"Metabolic coupling and the Reverse Warburg Effect in cancer: implications for novel biomarker and anticancer agent development","volume":"44","author":"Wilde","year":"2017","journal-title":"Semin. Oncol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3109\/10929088.2015.1076039","article-title":"One-step reconstruction with a 3D-printed, biomechanically evaluated custom implant after complex pelvic tumor resection","volume":"20","author":"Wong","year":"2015","journal-title":"Comput. Aided Surg."},{"key":"B80","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.chembiol.2017.02.010","article-title":"Hedgehog signaling: from basic biology to cancer therapy","volume":"24","author":"Wu","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"E50","DOI":"10.1097\/BRS.0000000000001179","article-title":"Reconstruction of the upper cervical spine using a personalized 3D-printed vertebral body in an adolescent with ewing sarcoma","volume":"41","author":"Xu","year":"2016","journal-title":"Spine (Phila Pa 1976)"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.3390\/cancers13102390","article-title":"Chondrosarcoma-from molecular pathology to novel therapies","volume":"13","author":"Zajac","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell Mol. Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1158\/1078-0432.CCR-12-3647","article-title":"Functional profiling of receptor tyrosine kinases and downstream signaling in human chondrosarcomas identifies pathways for rational targeted therapy","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"977935","DOI":"10.3389\/fonc.2022.977935","article-title":"Global research trend of esophageal squamous cell carcinoma from 2012 to 2022: a bibliometric analysis","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1431958\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T04:35:06Z","timestamp":1722573306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1431958\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":85,"alternative-id":["10.3389\/fphar.2024.1431958"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1431958","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"article-number":"1431958"}}